gmp
gmp

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): IBC-Ab002

            Therapeutic Area: Neurology Product Name: IBC-Ab002

            Highest Development Status: Phase I Product Type: Large molecule

            Partner/Sponsor/Collaborator: Alzheimer’s Association

            Deal Size: $1.0 million Upfront Cash: Undisclosed

            Deal Type: Funding September 01, 2020

            Details:

            The grant will phase 1 clinical trial to examine safety and activity of its proprietary antibody, IBC-Ab002, targeted to enhance the immune system and induce brain repair processes in individuals with Alzheimer’s disease.